Robert L. Frye, MD*
*Adapted for publication in Annals of Internal Medicine by Jennifer Fisher Wilson and Michael Berkwits, MD, MSCE.
Requests for Single Reprints: Robert L. Frye, MD, Mayo Clinic, Siebens Building, Room 640, 200 First Street SW, Rochester, MN 55905; e-mail, email@example.com.
Potential Financial Conflicts of Interest: Consultancies: Cleveland Clinic, Sanofi-Synthelabo Research. Honoraria: Cleveland Clinic, Sanofi-Synthelabo Research; all honoraria were paid to the Mayo Clinic and not the author. Grants received: Abbott Laboratories, Bayer Diagnostics, Becton Dickinson, Centocor, Bristol-Myers Squibb Medical Imaging (formerly DuPont), Eli Lilly and Company, Fujisawa Healthcare, GlaxoSmithKline, Merck & Co., Pfizer; all were received in support of BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes), a National Heart, Lung, and Blood Institute and National Institute of Diabetes and Digestive and Kidney Diseases Clinical Trial.
Frye RL. Update in Cardiology. Ann Intern Med. ;147:180–186. doi: 10.7326/0003-4819-147-3-200708070-00007
Download citation file:
Published: Ann Intern Med. 2007;147(3):180-186.
Cardiology, Coronary Heart Disease, Emergency Medicine, Updates.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use